You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Litigation Details for Gilead Sciences, Inc. v. Lupin Ltd. (D. Del. 2022)

✉ Email this page to a colleague

« Back to Dashboard

Gilead Sciences, Inc. v. Lupin Ltd. (D. Del. 2022)

Docket	⤷ Sign Up	Date Filed	2022-05-09
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Maryellen Noreika
Jury Demand	None	Referred To
Parties	LAURUS LABS LIMITED
Patents	10,385,067; 10,548,846; 9,708,342
Attorneys	Sharon Lin
Firms	Phillips, McLaughlin & Hall, P.A.
Link to Docket	External link to docket

Small Molecule Drugs cited in Gilead Sciences, Inc. v. Lupin Ltd.

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Details for Gilead Sciences, Inc. v. Lupin Ltd. (D. Del. 2022)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2022-05-09	1	Complaint	expiration of U.S. Patent Nos. 9,708,342, 10,385,067, and 10,548,846 (collectively, “the Patents-In-Suit”). … the ’342 patent and holds title to the ’342 patent. 41. The ’342 patent claims, among…of the ’067 patent and holds title to the ’067 patent. 44. The ’067 patent claims, among…of the ’846 patent and holds title to the ’846 patent. 47. The ’846 patent claims, among…Defendant has infringed the ’342 patent, the ’067 patent, and/or the ’846 patent under 35 U.S.C. § 271(e)(2	External link to document
2023-11-15	167	Patent/Trademark Report to Commissioner of Patents	Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,708,342 B2; 10,385,067 B2; 10,548,… 9 May 2022 1:22-cv-00615 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2023-11-16	171	Patent/Trademark Report to Commissioner of Patents	Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,708,342 B2; 10,385,067 B2; 10,548,… 9 May 2022 1:22-cv-00615 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2022-05-09	3	ANDA Form	Expiration of Patent: U.S. Patent No. 9,708,342: June 19, 2035. U.S. Patent No. 10,385,067: June 19, 2035… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2035. U.S. Patent No. 10,548,846: November 8, 2036.Thirty Month Stay Deadline: 8/7/2025. (srs) (Entered… 9 May 2022 1:22-cv-00615 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.